BioGaia AB (publ) (BIOG-B.ST)
BIOG-B.ST Stock Price Chart
Explore BioGaia AB (publ) interactive price chart. Choose custom timeframes to analyze BIOG-B.ST price movements and trends.
BIOG-B.ST Company Profile
Discover essential business fundamentals and corporate details for BioGaia AB (publ) (BIOG-B.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
3 Jan 2000
Employees
224.00
Website
https://www.biogaia.comCEO
Theresa P. Agnew
Description
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylorithe gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.
BIOG-B.ST Financial Timeline
Browse a chronological timeline of BioGaia AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 10 Feb 2026
Upcoming earnings on 20 Oct 2025
Earnings released on 18 Jul 2025
EPS came in at kr 0.87 falling short of the estimated kr 0.90 by -3.44%, while revenue for the quarter reached kr 404.69M , beating expectations by +16.29%.
Dividend declared on 8 May 2025
A dividend of kr 6.90 per share was announced, adjusted to kr 6.90. The dividend was paid on 14 May 2025.
Earnings released on 5 May 2025
EPS came in at kr 0.79 falling short of the estimated kr 0.80 by -1.25%, while revenue for the quarter reached kr 366.27M , missing expectations by -1.91%.
Earnings released on 12 Feb 2025
EPS came in at kr 0.81 surpassing the estimated kr 0.57 by +42.11%, while revenue for the quarter reached kr 364.83M , beating expectations by +9.07%.
Earnings released on 22 Oct 2024
EPS came in at kr 0.36 falling short of the estimated kr 0.64 by -43.75%, while revenue for the quarter reached kr 303.97M , missing expectations by -8.85%.
Earnings released on 23 Jul 2024
EPS came in at kr 1.10 surpassing the estimated kr 0.95 by +15.79%, while revenue for the quarter reached kr 384.12M , beating expectations by +7.30%.
Dividend declared on 8 May 2024
A dividend of kr 6.90 per share was announced, adjusted to kr 6.90. The dividend was paid on 15 May 2024.
Earnings released on 7 May 2024
EPS came in at kr 1.21 surpassing the estimated kr 0.96 by +26.04%, while revenue for the quarter reached kr 369.80M , beating expectations by +10.55%.
Earnings released on 7 Feb 2024
EPS came in at kr 0.67 surpassing the estimated kr 0.59 by +13.56%, while revenue for the quarter reached kr 297.77M , beating expectations by +2.70%.
Earnings released on 20 Oct 2023
EPS came in at kr 1.01 surpassing the estimated kr 0.78 by +29.49%, while revenue for the quarter reached kr 317.69M , beating expectations by +12.38%.
Earnings released on 21 Jul 2023
EPS came in at kr 0.80 surpassing the estimated kr 0.75 by +6.67%, while revenue for the quarter reached kr 315.22M , beating expectations by +3.35%.
Dividend declared on 8 May 2023
A dividend of kr 2.90 per share was announced, adjusted to kr 2.90. The dividend was paid on 12 May 2023.
Earnings released on 5 May 2023
EPS came in at kr 1.15 surpassing the estimated kr 0.88 by +30.68%, while revenue for the quarter reached kr 365.82M , beating expectations by +17.25%.
Earnings released on 3 Feb 2023
EPS came in at kr 1.38 surpassing the estimated kr 0.61 by +126.23%, while revenue for the quarter reached kr 274.28M , missing expectations by -12.09%.
Earnings released on 21 Oct 2022
EPS came in at kr 0.79 surpassing the estimated kr 0.48 by +64.58%, while revenue for the quarter reached kr 257.73M , beating expectations by +7.86%.
Earnings released on 22 Jul 2022
EPS came in at kr 0.78 surpassing the estimated kr 0.46 by +69.57%, while revenue for the quarter reached kr 288.09M , beating expectations by +12.42%.
Stock split effective on 18 May 2022
Shares were split 5 : 1 , changing the number of shares outstanding and the price per share accordingly.
Dividend declared on 9 May 2022
A dividend of kr 14.92 per share was announced, adjusted to kr 2.98. The dividend was paid on 13 May 2022.
Earnings released on 6 May 2022
EPS came in at kr 0.76 surpassing the estimated kr 0.64 by +18.75%, while revenue for the quarter reached kr 283.86M , beating expectations by +12.02%.
Earnings released on 4 Feb 2022
EPS came in at kr 0.38 falling short of the estimated kr 0.68 by -44.12%, while revenue for the quarter reached kr 206.16M , beating expectations by +8.75%.
Earnings released on 21 Oct 2021
EPS came in at kr 0.52 surpassing the estimated kr 0.28 by +85.71%, while revenue for the quarter reached kr 173.84M .
Earnings released on 12 Aug 2021
EPS came in at kr 0.54 falling short of the estimated kr 0.58 by -6.90%, while revenue for the quarter reached kr 203.13M .
Dividend declared on 7 May 2021
A dividend of kr 3.41 per share was announced, adjusted to kr 0.68. The dividend was paid on 14 May 2021.
Earnings released on 6 May 2021
EPS came in at kr 0.50 surpassing the estimated kr 0.38 by +31.58%, while revenue for the quarter reached kr 201.98M .
Earnings released on 4 Feb 2021
EPS came in at kr 0.40 falling short of the estimated kr 0.62 by -35.48%, while revenue for the quarter reached kr 187.61M .
Earnings released on 23 Oct 2020
EPS came in at kr 0.24 falling short of the estimated kr 0.44 by -45.45%, while revenue for the quarter reached kr 131.96M .
BIOG-B.ST Stock Performance
Access detailed BIOG-B.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.